CW April 2001

category image Volume 10
Issue Number 4
April 2001
ISSN 10593802

Gene Therapy to Correct Chromosomal Fragile Site

Oral administration of recombinant viral DNA carrying a human tumor suppressor gene FHIT, is found to prevent significantly the development of chemically induced tumor in mouse lacking one allele of the gene.
Go to Previous Page
Go to Next Page

Source & Additional Reading

K. R. Dumon et al., Proceedings of the National Academy of Sciences, USA, March 13, 2001.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW April 2001

Purchase Downloadable Full-text PDF of Complete Issue: $10.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login